Follow the HLS share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, HLS has recorded 11 insider filings. Market capitalisation: €67.4m. The latest transaction was filed on 8 September 2026 (Initial Substantial Holding). Among the most active insiders: its controlled bodies corporate listed in Annexure A. Every trade is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 16,179 of 29,064 companies
48.9
score / 100
Value
60
Quality
38
FCF yld23%
Earn yld-18%
EV/EBITDA7.3x
ROE-14%
Gross mgn82%
Net mgn-22%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.